R
Ryan B. Perumpail
Researcher at University of California, Los Angeles
Publications - 53
Citations - 2442
Ryan B. Perumpail is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Liver transplantation & Hepatitis C. The author has an hindex of 16, co-authored 50 publications receiving 1956 citations. Previous affiliations of Ryan B. Perumpail include Albert Einstein College of Medicine & Northwestern University.
Papers
More filters
Journal ArticleDOI
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong,Maria Aguilar,Ramsey Cheung,Ramsey Cheung,Ryan B. Perumpail,Stephen A. Harrison,Zobair M. Younossi,Zobair M. Younossi,Aijaz Ahmed +8 more
TL;DR: Patients with NASH are less likely to undergo liver transplantation (LT) andLess likely to survive for 90 days on the waitlist than patients with HCV, ALD, or HCV and ALD.
Journal ArticleDOI
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
George Cholankeril,Robert J. Wong,Menghan Hu,Ryan B. Perumpail,Eric R. Yoo,Puneet Puri,Zobair M. Younossi,Stephen A. Harrison,Aijaz Ahmed +8 more
TL;DR: Currently, NASH is the most rapidly growing indication for LT in the US, despite resurgence in ALD, and NASH remains the second leading indication forLT.
Journal ArticleDOI
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Ryan B. Perumpail,Robert J. Wong,Aijaz Ahmed,Stephen A. Harrison,Stephen A. Harrison,Stephen A. Harrison +5 more
TL;DR: A case series highlights the development of NAFLD/NASH and MS-associated HCC in the absence of cirrhosis in the US population and raises the important question of HCC screening for this at-risk group.
Journal ArticleDOI
Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma.
TL;DR: Emerging data are suggesting that a small proportion of patients with NAFLD may be at higher risk for HCC in the absence of cirrhosis - implicating obesity and diabetes mellitus as potential risk factors for H CC.
Journal ArticleDOI
The importance of a multidisciplinary approach to hepatocellular carcinoma.
Osama Siddique,Eric R. Yoo,Ryan B. Perumpail,Brandon J Perumpail,Andy Liu,George Cholankeril,Aijaz Ahmed +6 more
TL;DR: A multidisciplinary team approach provides a timely, individualized treatment plan, which can vary from curative surgery in patients with early-stage HCC to palliative/hospice care in patientsWith metastatic HCC.